Kristiana Rozensteina

Kristiana Rozensteina

Auto-generated profile, based on publicly available information

Kristiana Rozensteina

Laboratory of Sports and Nutrition Research, Riga Stradins University, Riga, Latvia

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 December 2025 in European Journal of Sport Science
Verified
Journal Article
Open access
DLDiana Lismane
Diana Lismane
DVDeina Vilite
Deina Vilite
Jelena RaudenieceJelena Raudeniece
Jelena Raudeniece
LLLinda Laizane
Linda Laizane
GGGita Gersone
Gita Gersone
Dace ReihmaneDace Reihmane
Dace Reihmane
Although acute exercise can have positive effects on individual's cognitive functioning, performing ultra‐endurance race can diminish these benefits. No previous studies have examined if cognitive decline can be estimated by subjective perception; thus, changes in cognitive functions and their relation to subjectively reported parameters (SRPs) were evaluated. Before, immediately after, and ~20h post ultra‐endurance race, 43 amateur cyclists filled out questionnaire rating SRPs and performed digit symbol test (DST), stroop test (ST), finger tapping test (FTT). Changes between three timepoints were determined by one‐way repeated measures ANOVA or Friedman test. Mixed model regression was used to test relationship between cognitive functions and SRPs. DST results exhibit no changes in post‐race measurement, but an improvement of performance in recovery period was observed for correct number count (increase by 8,6 taps per 2 min, p < 0.001) and mean reaction time (decrease by 190 ms, p < 0.001). In ST, average time for correct reactions post‐race increased in all three stages by 22, 35, and 68 ms, respectively ( p < 0.001), with no changes in accuracy. For FTT, non‐dominant hand showed decline in performance post‐race. Changes in several SRPs (effort to answer the questions, physical strength, sleep quality, and stress levels during the previous day) were associated with changes in participants' cognitive performance. Short‐term decline in cognitive functions was observed after ultra‐endurance race, indicating possible increase in accident risk for participants. SRPs assessing sleep, current effort, stress, and physical strength, but not fatigue, may be reliable predictors of these changes.

26 August 2026 in Scientific Reports
Verified
Journal Article
Open access
PDF file
LLLinda Laizane
Linda Laizane
VPValdis Pirsko
Valdis Pirsko
DVDeina Vilite
Deina Vilite
IMIngrida Mirte
Ingrida Mirte
KRKristiana Rozensteina
Kristiana Rozensteina
Dace ReihmaneDace Reihmane
Dace Reihmane
Exercise-induced myokines mediate the systemic communication between muscle and tumor cells. However, how exercise-conditioned serum (ECS) affects different breast cancer (BC) subtypes remains largely unknown. This study investigated the intensity-dependent effects of an acute session of aerobic exercise on the myokine profile and the subsequent anti-cancer effect (ACE) of ECS on BC cell lines in vitro. In a crossover design, 18 premenopausal women completed three visits: a baseline measurement session followed by two 45-min continuous exercise treadmill protocols at 75% (CE75) and 45% (CE45) of VO 2 peak. Blood samples were collected 5 min before exercise, during exercise at 15, 30, and 45 (last minute of exercise) minutes. Six myokines (OSM, SPARC, IL-6, BDNF, FGF-21, decorin) were quantified using Miliplex Human Cytokine/Chemokine/Growth Factor Panel A, HCYTA-60K-06, and Decorin Duo Set ELISA kit. Several BC cell lines, including HER2-positive (SK-BR-3) and triple-negative (MDA-MB-231, HCC1937, HCC1143), were treated with 25% ECS for 72 h to assess cell viability using ATP-based luminescence assay CellTiter-Glo 2.0 (Promega) after CE75 and CE45. CE75 elicited a significantly greater increase in decorin ( p < 0.01) and SPARC ( p = 0.03) systemic levels, while OSM peaked at 30 min ( p = 0.042). The SK-BR-3 cell line reduced ATP-based viability after exposure to ECS at both intensities (CE45: p = 0.005; CE75: p = 0.002). In contrast, the aggressive MDA-MB-231 phenotype showed intensity-dependent inhibition, with a statistically significant difference between CE75 and CE45 at 45 min ( p = 0.043). Furthermore, strong positive correlations were found between IL-6, FGF-21, and OSM during both protocols. Notably, the strongest association was found between ΔOSM and ΔFGF-21 (CE75: p < 0.01, ρ = 0.80; CE45: p < 0.001, ρ = 0.92.). Moreover, ΔMDA-MB-231 ATP levels correlated with ΔFGF-21 ( p < 0.05, ρ = 0.67) at CE75. The effect of ECS depends on BC cell line subtype and exercise intensity, with SK-BR-3 being most susceptible and higher intensity being more effective. These preliminary in vitro findings indicate that both BC subtype and exercise intensity are relevant considerations for future work toward precision exercise prescription and require validation in BC patient cohorts.

31 July 2026 in European Journal of Pediatrics
Verified
Journal Article
Open access
PDF file
LBLizete Braivo
Lizete Braivo
KRKristiāna Rozenšteina
Kristiāna Rozenšteina
Dace ReihmaneDace Reihmane
Dace Reihmane
MZMārtiņš Zvackis
Mārtiņš Zvackis
AKAnda Kivite-Urtane
Anda Kivite-Urtane
IKIveta Dzivite Krisane
Iveta Dzivite Krisane
The incidence of type 1 diabetes (T1D) among the paediatric population in Latvia is gradually increasing, and ~ 50% of patients with newly diagnosed T1D present with diabetic ketoacidosis (DKA). This study aimed to initiate T1D screening for high-risk children to reduce the rate of DKA and enable early pre-symptomatic intervention. This prospective observational study was conducted at Children’s Clinical University Hospital (CCUH) from March 2024 to February 2026. Siblings aged 2–17 years of patients with T1D were invited to participate. The parents completed a short questionnaire regarding participants’ health status and family history. Screening was performed in two stages: (1) 3-screen ELISA and insulin autoantibody (IAA) ELISA testing; if ≥ 1 positive then (2) ELISA testing for all four autoantibodies (AAs) separately: IAA, insulinoma-associated antigen-2 (IA-2A), zinc transporter 8 (ZnT8A) and glutamic acid decarboxylase 65 (GAD-65A) antibodies, glycaemic status assessment, and screening for celiac disease and autoimmune thyroiditis. Participants with ≥ 2 AAs in the second screening underwent a 2 h-oral glucose tolerance test (OGTT). Parents of participating children were screened for anxiety and depression using GAD-7 (general anxiety disorder 7) and PHQ-9 (patient health questionnaire-9) instruments. Of the 83 participants in the first screening, 26 (31.3%) had ≥ 1 positive test results. This group more frequently had ≥ 1 family member with T1D than those with negative results (30.8 versus 5.3% respectively, p = 0.003). In the second screening stage, 13 participants (50%) tested negative for all 4 AAs, 9 (10.8%) had one positive AA (AA +), one participant had two AA + , and three children had three AA + . At the time of the second screening, all participants had normal glycaemic measurements, negative results for celiac disease and autoimmune thyroiditis screening. During observation period, two participants developed stage 3 T1D. Following the OGTT, another participant was diagnosed with stage 2 T1D, but two other participants with ≥ 2 AA + remained normoglycemic. The overall prevalence of depression and anxiety was similarly high among parents of children with both positive and negative T1D screening results; however, parents in the positive screening group more frequently exhibited severe anxiety. Conclusion: Positive T1D screening with ≥ 2 AAs was observed in 5 (6.02%) participants. Three participants progressed to stage 2 or stage 3 T1D during follow-up, corresponding to a positive predictive value of 60%, within a relatively short observation period of 10–24 months. These findings support the implementation of T1D screening in Latvia, particularly in high-risk populations. What is Known: • Islet AA testing for several years has been used to screen for T1D in multiple international studies and national screening programs. • Timely detection of islet AA can prevent from DKA development and ensure presymptomatic insulin treatment with fewer complications. What is New: • These data are of particular significance, because no prior screening initiatives for T1D have been reported in Latvia. • There is an urgent need to improve recognition of T1D in Latvia to decrease rates of DKA and other complications, and screening could be an effective tool for that.